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An Association Between Ulcerative Colitis and Atopic
Dermatitis, Diseases of Impaired Superﬁcial Barriers
To the Editor:
Atopic dermatitis (AD) and inflammatory bowel disease
(IBD) are disorders in which mucocutaneous barrier dys-
function and immunologic phenomena play a role in patho-
genesis (Ogawa and Yoshiike, 1993; Taieb, 1999). It has
been suggested that these two conditions may coexist with
greater than expected frequency (Pugh et al, 1979), but data
are scarce. Between 1992 and 2003, a total of 47,862 adult
AD patients ages 18–62 y (25,512 males, 22,350 females;
39,450 out-patients, 7412 in-patients) were evaluated and
treated for AD at Tosashimizu Hospital and its 11 satellite
clinics throughout Japan. Patients were selected only for
suspicion or previous diagnosis of AD, and each diagnosis
of AD by Hanifin and Rajka criteria was confirmed by one or
more of our staff dermatologists. AD severity was assessed
as described in Table I. All of the AD patients were con-
secutively evaluated by questionnaire for evidence of IBD
(macroscopic blood in stool, chronic abdominal pain,
chronic diarrhea, or previous diagnosis of ulcerative colitis
(UC) or Crohn’s disease (CD)). Patients with chronic pain
and diarrhea were tested for fecal occult blood. Those
testing positive, as well as patients with a history of blood in
stool or previous diagnosis of UC or CD for whom inade-
quate documentation was available, were asked to undergo
colonoscopy and biopsy. As controls, 600 patients with
other skin disorders (352 patients with contact dermatitis,
173 patients with cutaneous dermatophyte infection, and
75 patients with psoriasis vulgaris; ages 20–53 y, equal
male:female ratio) were similarly screened. Informed con-
sent was obtained from each subject.
Out of the 47,862 consecutive AD patients, 452 under-
went colonoscopy and biopsy. A diagnosis of UC was con-
firmed in 112 and a diagnosis of CD was confirmed in 6
(prevalence of 0.234% and 0.012%, respectively). In addi-
tion, 15 of the AD patients with clinical criteria for IBD, and
four with a prior incompletely documented diagnosis of UC
or CD refused colonoscopy and were therefore not included
among the patients with a diagnosis of UC or CD. Among
the 600 control patients, 11 underwent colonoscopy and
biopsy. No cases of UC or CD were identified.
The estimated prevalence of UC and CD reported in Ja-
pan in the annual report of the Japanese Ministry of Health
(2002, latest figures available) was 49,000 and 16,000 cas-
es, respectively. The Japanese population in 2002 was ap-
proximately 127.4 million. The estimated frequency of UC in
the Japanese population is thus 0.038%, and that of CD is
0.013%. UC is thus estimated to be more frequent in adult
AD patients than in the Japanese population with an odds
ratio of 6.1 [5.1–7.3, 95% confidence interval], whereas CD
was not more prevalent in the AD patients than in the Jap-
anese population (odds ratio 1.0 [0.45–2.2]). There was no
correlation between the severity of AD and the prevalence
of associated UC or CD (Table I).
These results suggest an association between AD and
UC. The AD patients came from all parts of Japan and
showed a wide range of skin disease activity, and the in-
creased association of UC was found irrespective of AD
disease activity. These three factors substantially reduce
the likelihood that the apparent association with UC is an
artifact of patient selection (Conn et al, 1979). There was no
increased frequency of CD in the AD patients, although
the age distributions of UC and CD in Japan are almost the
same (Yoshida and Murata, 1990). This finding reduces the
likelihood that the apparent association with UC is an ar-
tifact of the surveillance methods or criteria for diagnosis.
The absence of UC or CD in the control patients, despite the
known association of IBD with psorasis (Brophy et al, 2001),
also suggests absence of bias in surveillance or observa-
tion, although the number of control subjects is relatively
small. An estimated 30%–45% of CD patients in Japan do
not show colonic involvement (Yao et al, 2000), and our
surveillance method thus might have somewhat underesti-
mated the prevalence of CD in the AD patients. Even if the
odds ratio for CD in the AD patients increased to 1.5 (nine
cases instead of six), however, it would still be significantly
lower than the UC odds ratio at po0.0001.
The prevalence of CD in Japan that we calculated agrees
well with other recent estimates (Yao et al, 2000), whereas
recent published data on UC prevalence are not available.
The prevalence rates of UC and CD that we calculated for
2002 are each approximately 2.1-fold higher than those re-
ported in a 1991 survey (Morita et al, 1995), a fold increase
closely matching that reported for CD between 1991 and
1998 (Yao et al, 2000). Overall, the observations and cal-
culations in our study seem sufficiently free of sources of
potential bias and error to support the provisional conclu-
sion of a significantly increased prevalence of UC in the AD
patients.
Both AD and UC are characterized by inflammation in the
superficial layers of mucocutaneous tissue, in contrast to
CD, in which the lesions are deep and often transmural.
Asthma and allergic rhinitis, which are often associated with
AD (Umeki, 1994), are also diseases affecting superficial
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mucosal layers. Therefore, AD seems to be the disease of
the impaired superficial barriers of whole body. The inflam-
matory infiltrate in these disorders, like AD, characteristi-
cally shows a TH2 pattern (Taieb, 1999). The cytokine
pattern found in UC mucosa has usually been characterized
primarily as TH2, in contrast to the TH1 pattern seen in CD
(Inoue et al, 1999; Sawa et al, 2003). Although AD, UC,
allergic rhinitis, and bronchial asthma all have important
immunologic components, no one specific antigen is
thought to be responsible for any of these disorders. Rath-
er, antigen specific immune responses are more likely to
result from impairment of barrier function that is a more
primary part of the pathogenesis of these disorders.
Genome-wide scans have identified loci with linkage to
IBD (Wild and Rioux, 2004) and other loci with suggestive
linkage to AD (Bowcock and Cookson, 2004). Although no
direct genetic linkage between the two disorders has been
identified, a haplotype on chromosome 5q31 that contains a
cluster of atopy-related genes including interleukin (IL)-4
and IL-13 is strongly linked to CD and probably also to UC
(Giallourakis et al, 2003), and shows linkage to serum IgE
levels in AD families (Cookson et al, 2001).
In summary, our large 11 y prospective study suggests
an association between AD and UC, and recent data from
several sources suggest potential sharing of TH2 cytokine-
related pathways in the pathogenesis of these two disor-
ders of barrier dysfunction. This intriguing association mer-
its further investigation.
Yukie Niwa, Hajime Sumi,w and Hirohiko Akamatsuz
Niwa Institute for Immunology and Tosashimizu Hospital, Tos-
ashimizu, Kochi, Japan; wDepartment of Internal Medicine, National
Cancer Center Hospital East, Kashiwa, Japan; zDepartment of Der-
matology, Fujita Health University School of Medicine, Toyoake,
Aichi, Japan
DOI: 10.1111/j.0022-202X.2004.23462.x
Manuscript received April 9, 2004; revised July 10, 2004; accepted for
publication July 12, 2004
Address correspondence to: Yukie Niwa, MD, PhD, Niwa Institute for
Immunology and Tosashimizu Hospital, 5-3 Saiwai-cho, Tosashimizu,
Kochi, 787-0306, Japan. Email: yniwa@lime.ocn.ne.jp
References
Bowcock AM, Cookson WO: The genetics of psoriasis, psoriatic arthritis and
atopic dermatitis. Hum Mol Genet 13 (Spec No. 1):R43–R55, 2004
Brophy S, Pavy S, Lewis P, et al: Inflammatory eye, skin, and bowel disease
in spondyloarthritis: Genetic, phenotypic, and environmental factors.
J Rheumatol 28:2667–2673, 2001
Conn HO, Snyder N, Atterbury CE: The Berkson bias in action. Yale J Biol Med
52:141–147, 1979
Cookson WO, Ubhi B, Lawrence R, et al: Genetic linkage of childhood atopic
dermatitis to psoriasis susceptibility loci. Nat Genet 27:372–373, 2001
Giallourakis C, Stoll M, Miller K, et al: IBD5 is a general risk factor for inflam-
matory bowel disease: Replication of association with Crohn disease
and identification of a novel association with ulcerative colitis. Am J Hum
Genet 73:205–211, 2003
Inoue S, Matsumoto T, Iida M, Mizuno M, Kuroki F, Hoshika K, Shimizu M:
Characterization of cytokine expression in the rectal mucosa of ulcer-
ative colitis: Correlation with disease activity. Am J Gastroenterol 94:
2441–2446, 1999
Morita N, Toki S, Hirohashi T, et al: Incidence and prevalence of inflammatory
bowel disease in Japan: Nationwide epidemiological survey during the
year 1991. J Gastroenterol 30 (Suppl. 8):1–4, 1995
Niwa Y, Sumi H, Kawahira K, Terashima T, Nakamura T, Akamatsu H: Protein
oxidative damage in the stratum corneum: Evidence for a link between
environmental oxidants and the changing prevalence and nature of atopic
dermatitis in Japan. Br J Dermatol 149:248–254, 2003
Ogawa H, Yoshiike T: A speculative view of atopic dermatitis: Barrier dysfunction
in pathogenesis. J Dermatol Sci 5:197–204, 1993
Pugh SM, Rhodes J, Mayberry JF, Roberts DL, Heatley RV, Newcombe RG:
Atopic disease in ulcerative colitis and Crohn’s disease. Clin Allergy
9:221–223, 1979
Sawa Y, Oshitani N, Adachi K, Higuchi K, Matsumoto T, Arakawa T: Compre-
hensive analysis of intestinal cytokine messenger RNA profile by real-time
quantitative polymerase chain reaction in patients with inflammatory
bowel disease. Int J Mol Med 11:175–179, 2003
Taieb A: Hypothesis: From epidermal barrier dysfunction to atopic disorders.
Contact Dermatitis 41:177–180, 1999
Umeki S: Allergic cycle: Relationships between asthma, allergic rhinitis, and
atopic dermatitis. J Asthma 31:19–26, 1994
Wild GE, Rioux JD: Genome scan analyses and positional cloning strategy in IBD:
Successes and limitations. Best Pract Res Clin Gastroenterol 18:541–553,
2004
Yao T, Matsui T, Hiwatashi N: Crohn’s disease in Japan: Diagnostic criteria and
epidemiology. Dis Colon Rectum 43:S85–S93, 2000
Yoshida Y, Murata Y: Inflammatory bowel disease in Japan: Studies of epidemi-
ology and etiopathogenesis. Med Clin North Am 74:67–90, 1990
Table I. Lack of correlation between AD severity and associated IBD
Patients
AD disease activity
Total
AD versus all patients
Mild Moderate Severe Extra-severe v2 p
AD (all) 4748 19,862 21,567 1685 47,862
AD with UC 14 40 52 6 112 2.7 0.4
AD with CD 1 2 3 0 6 0.6 0.9
Severity was assessed by modified AD score (Niwa et al, 2003): extra-severe X220, severe 170–219, moderate 120–169, mild p119. Score¼
Ia  1þ IIa  2þ IIIa  3, where Ia is the percentage of body surface area with mild lesions (erythema or papules), IIa is the percentage with moderate
lesions (elevated erythema, papules, or scratch marks), and IIIa is the percentage with severe lesions (lichenification or prurigo nodularis).
AD, atopic dermatitis; IBD, inflammatory bowel disease; UC, ulcerative colitis; CD, Crohn’s disease.
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